Page 29 - 10 Most Trusted Diagnostic Companies in India 2022
P. 29

FOCUS POINT


 projects  of  NVNR  Power  and   tinib  oral  capsules, for the treat-  GOVERNMENT INITIATIVES  tion and innovation infrastructure.

 Infra in Hyderabad. The company   ment  of  kidney  cancer  in  India.  Some  of  the  initiatives

 will  acquire  26%  share  capital  in   taken by the  Government to   •  In August 2021,  Union Health

 both  companies  with  an  US$  1.5   •  In February 2021, Natco Pharma   promote  the  pharmaceutical  Minister, Mr. Mansukh Manda-

 million investment. The acquisi-  launched  Brivaracetam  for  the   viya  announced  that  an  addi-
 tion is expected to be completed   treatment of epilepsy in India.  sector  in  India  are  as  follows:  tional  number  of  pharmaceutical

 by the end  of March 2021.
 •  In  February  2021,  the  Russian   •  India could restart deliveries of   companies  in  India  are  expected

 •  In February 2021,  the Telan-  Ministry  of  Health  allowed  Glen-  COVID-19 shots to global vaccine-  to  commence  manufacturing  of

 gana  government  partnered  mark  Pharmaceuticals  to  market   sharing platform COVAX in Novem-  anti-coronavirus vaccines by Octo-

 with  Cytiva  to  open  a  ‘Fast   its  novel  fixed-dose  combi-  ber-December  2021  for  the  first   ber-November 2021. This move is

 Trak’ lab  to strengthen the   nation  nasal  spray  in  Russia.  time  since  April  2021.  The  World   expected to further boost the vacci-

 biopharma  industry  of  the  state.
 •  In January 2021,  the  Central   Health Organization (WHO),  which   nation drive across  the  country.


 •  In February 2021,  Glenmark   government announced to set up   co-leads COVAX, has been pushing

 Pharmaceuticals Limited launched   three bulk drug parks at a cost of Rs.   India  to resume  supplies  for  the   •  In  June  2021,  Finance Minister
 SUTIB,  a  generic  version  of  Suni-  14,300 crore (US$ 1,957 million) to  programme,  particularly  after  it   Ms. Nirmala Sitharaman announced

 tinib  oral  capsules,  for  the  treat  manufacture chemical compounds   sent  ~4  million doses  to  neigh-  an additional outlay of Rs. 197,000

 or active pharmaceutical  ingre                                   crore (US $26,578.3 million) that will
 dients  (APIs)  for  medicines  and   bours and allies  in October  2021.

 reduce  imports  from  China.                                     be utilised over five years for the
            •  In  November  2021,  PM  Mr.                        pharmaceutical  PLI  scheme  in  13

 •  PharmEasy  received  US$  Narendra  Modi inaugurated  the      key sectors such as active pharma-

 300  million  in  July  2021  from  its   first Global  Innovation Summit  of   ceutical ingredients, drug interme-

 existing  investors after acquiring   the pharmaceuticals  sector. The   diaries and key starting materials.

 Thyrocare,  the  diagnostic  firm.   summit  will  have  12 sessions  and

 These  funds  will  be  utilised  to   over 40 national and international   •  As of  August 31,  2021,  the  PLI

 continue  Thyrocare’s  acquisition

 process.  After  the  transaction   speakers deliberating on a range   scheme received a good response
 is  completed, the online phar-  of  subjects  including  regulatory   from the industry with a total

 macy plans to float the company   environment,  funding  for  innova-  of  278 applications. This  is  likely

 on  the  Indian  Stock  Exchange.  tion,  industry-academia  collabora  to benefit  55 manufacturers.


 |28  thecorporatereview.com  | India  | Vol. 3  |  Issue  3 | March 2022                                   |29
   24   25   26   27   28   29   30   31   32   33   34